Modulation of diacylglycerol acyltransferase 1 expression

Details Modulation of diacylglycerol acyltransferase 1 expression Modulation of diacylglycerol acyltransferase 1 expression

2004-03-18

2008-08-19

McGarry, Sean R (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S024100, C536S024500, C435S006120, C435S375000, C435S377000

Reexamination Certificate

active

07414033

ABSTRACT:
Compounds, compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase 1. The compositions comprise oligonucleotides, targeted to nucleic acid encoding diacylglycerol acyltransferase 1. Methods of using these compounds for modulation of diacylglycerol acyltransferase 1 expression and for diagnosis and treatment of disease associated with expression of diacylglycerol acyltransferase 1, such as obesity and obesity-related conditions, are provided.

REFERENCES:
patent: 5708160 (1998-01-01), Goh et al.
patent: 5998148 (1999-12-01), Bennett et al.
patent: 6100077 (2000-08-01), Sturley et al.
patent: 6344548 (2002-02-01), Farese, Jr. et al.
patent: 6444427 (2002-09-01), Ludwig et al.
patent: 6512099 (2003-01-01), Omura et al.
patent: 6607893 (2003-08-01), Ramharack et al.
patent: 6822141 (2004-11-01), Lardizabal et al.
patent: 6867039 (2005-03-01), Monia et al.
patent: 2002/0119138 (2002-08-01), Cases et al.
patent: 2002/0127627 (2002-09-01), Ramharack et al.
patent: 2002/0193315 (2002-12-01), Omura et al.
patent: 2003/0028923 (2003-02-01), Lardizabal et al.
patent: 2003/0073103 (2003-04-01), Ludwig et al.
patent: 2003/0100480 (2003-05-01), Smith et al.
patent: 2003/0104414 (2003-06-01), Attersand
patent: 2003/0115632 (2003-06-01), Lardizabal et al.
patent: 2003/0124126 (2003-07-01), Cases et al.
patent: 2003/0152574 (2003-08-01), Logan et al.
patent: 2003/0161831 (2003-08-01), Cases et al.
patent: 2003/0170691 (2003-09-01), Gimeno et al.
patent: 2003/0200563 (2003-10-01), Butler et al.
patent: 2003/0202968 (2003-10-01), Cases et al.
patent: 2004/0054177 (2004-03-01), Otake et al.
patent: 2004/0058820 (2004-03-01), Hagmann et al.
patent: 2004/0076977 (2004-04-01), Georges et al.
patent: 2004/0078836 (2004-04-01), Farese et al.
patent: 2004/0107459 (2004-06-01), Lardizabal et al.
patent: 2004/0122033 (2004-06-01), Nargund et al.
patent: 2004/0185559 (2004-09-01), Monia et al.
patent: 1308459 (2003-05-01), None
patent: WO 99/67268 (1999-12-01), None
patent: WO-00/78961 (2000-12-01), None
patent: WO-01/68848 (2001-09-01), None
patent: WO-01/77389 (2001-10-01), None
patent: WO-02/08260 (2002-01-01), None
patent: WO 02/062954 (2002-08-01), None
patent: WO 03/004630 (2003-01-01), None
Yu et al. Circulation vol. 100(18 Suppl.): 1745, Nov. 2, 1999.
Buhman et al., “DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis”,J. Biol. Chem. Jul. 12, 2002 277:25474-25479.
Cases et al., “Identification of a gene encoding an acyl CoA: diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis”,Proc. Natl. Acad. Sci. USA Oct. 27, 1998 95:13018-13023.
Cases et al., “Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members”,J. Biol. Chem. Oct. 19, 2001 276:38870-38876.
Chen et al., “Increased insulin and leptin sensitivity in mice lacking acyl CoA: diacylglycerol acyltransferase 1”,J. Clin. Invest. Apr. 2002 109:1049-1055.
Chen et al., “Leptin modulates the effects of acyl CoA: diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands”,J. Clin. Invest. Jan. 2002 109:175-181.
Cheng et al., “Human acyl-CoA: diacylglycerol acyltransferase is a tetrameric protein”,Biochem. J. Nov. 1, 2001 359:707-714.
Farese et al., “Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase”,Curr. Opin. Lipidol. Jun. 2000 11:229-234.
Lardizabal et al., “DGAT2 is a new diacylglycerol acyltransferase gene family: purification, cloning, and expression in insect cells of two polypeptides fromMortierella ramannianawith diacylglycerol acyltransferase activity”,J. Biol. Chem. Oct. 19, 2001 276:38862-38869.
Ludwig et al., “DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women”,Clin. Genet. Jul. 2002 62:68-73.
Meegalla et al., “Concerted elevation of acyl-coenzyme A: diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin”,Biochem. Biophys. Res. Commun. Nov. 1, 2002 298:317-323.
Oelkers et al., “Characterization of two human genes encoded acyl coenzyme A: cholesterol acyltransferase-related enzymes,”J. Biol. Chem. Oct. 9, 1998 273:26765-26771.
Smith et al., “Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking DGAT”,Nat. Genet. May 2000 25:87-90.
Tabata et al., “Xanthohumols, diacylglycerol acyltransferase inhibitors, fromHumulus lupulus”, PhytochemistryOct. 1997 46:683-687.
Tomoda et al., “Roselipins, inhibitors of diacylglycerol acyltransferase, produced byGliocladium roseumKF-1040”,J. Antibiot. (Tokyo) Aug. 1999 52:689-694.
Waterman et al., “Distinct ontogenic patterns or overt and latent DGAT activities of rat liver microsomes”,J. Lipid. Res. Sep. 2002 43:1555-1562.
Yu et al., “Posttranscriptional control of the expression and function of diacylglycerol acyltransferase-1 in mouse adipocytes”,J. Biol. Chem. Dec. 27, 2002 277:50876-50884.
Chin, Andrew “On the Preparation and Utilization of Isolated and Purified Oligonucleotides.” Document purportedly located on a CD-ROM and contributed to the public collection of the Katherine R. Everett Law Library of the University of North Carolina on Mar. 14, 2002.
Murray, Susan, et al., “Inhibition of DGAT1 with a Novel Optimized Antisense Inhibitor Lowers Plasma Glucose Levels,”Diabetes, 52(Supp. 1): p. A300, XP009077409 (2003).

Affiliated with

Also associated with

Rating

Modulation of diacylglycerol acyltransferase 1 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of diacylglycerol acyltransferase 1 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of diacylglycerol acyltransferase 1 expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3995554